GIP secretion inhibitor
    1.
    发明授权
    GIP secretion inhibitor 有权
    GIP分泌抑制剂

    公开(公告)号:US08283338B2

    公开(公告)日:2012-10-09

    申请号:US12325039

    申请日:2008-11-28

    IPC分类号: A01N43/04 A61K31/715

    CPC分类号: A61K31/734

    摘要: The present invention provides a postprandial GIP secretion inhibitor comprising potassium alginate as an active ingredient. The postprandial GIP secretion inhibitor of the present invention is useful as a medicine or a food product. The present invention also provides use of potassium alginate for the manufacture of a postprandial GIP secretion inhibitor. The present invention also provides a method for inhibiting postprandial GIP secretion, which comprises administering potassium alginate to a subject in need thereof or causing a subject in need thereof to consume potassium alginate.

    摘要翻译: 本发明提供一种餐后GIP分泌抑制剂,其包含藻酸钾作为活性成分。 本发明的餐后GIP分泌抑制剂可用作药物或食品。 本发明还提供藻酸钾用于制造餐后GIP分泌抑制剂的用途。 本发明还提供了抑制餐后GIP分泌的方法,其包括向有需要的受试者施用藻酸钾或使有需要的受试者摄入海藻酸钾。

    Agent for preventing or ameliorating obesity
    2.
    发明授权
    Agent for preventing or ameliorating obesity 有权
    预防或改善肥胖症的药剂

    公开(公告)号:US08338389B2

    公开(公告)日:2012-12-25

    申请号:US12817719

    申请日:2010-06-17

    IPC分类号: A01N43/04 A61K31/70

    CPC分类号: A61K31/734 C08B37/0084

    摘要: The present invention provides a method for preventing or ameliorating obesity, for inhibiting accumulation of visceral fat, for inhibiting accumulation of liver lipid, for preventing or ameliorating fatty liver, including using a material for a pharmaceutical product or food, which has inhibitory actions on body weight increase, accumulation of visceral fat and accumulation of liver lipid. The present invention is also directed to a method for preventing or ameliorating obesity, a method for inhibiting accumulation of visceral fat, a method for inhibiting accumulation of liver lipid, and a method for preventing or ameliorating fatty liver, which methods include administering potassium alginate to a subject in need thereof or having the subject take potassium alginate.

    摘要翻译: 本发明提供一种预防或改善肥胖症,抑制内脏脂肪积聚,抑制肝脂质积聚,预防或改善脂肪肝的方法,包括使用对身体有抑制作用的药物或食品的材料 体重增加,内脏脂肪积累和肝脏脂质积累。 本发明还涉及一种预防或改善肥胖症的方法,抑制内脏脂肪蓄积的方法,抑制肝脏脂肪蓄积的方法,以及预防或改善脂肪肝的方法,所述方法包括给予藻酸钾至 有需要的受试者或使受试者服用藻酸钾。

    PURIFIED ALGINIC ACID OR SALT THEREOF
    3.
    发明申请
    PURIFIED ALGINIC ACID OR SALT THEREOF 审中-公开
    纯化的酸或其盐

    公开(公告)号:US20110274793A1

    公开(公告)日:2011-11-10

    申请号:US13144980

    申请日:2010-01-19

    申请人: Tomohisa Ichiba

    发明人: Tomohisa Ichiba

    IPC分类号: A23L2/00 C08B37/04

    摘要: There is provided a purified alginic acid or a salt thereof having a low degree of coloration and a process for producing the same.A depolymerized alginic acid or a salt thereof having a weight-average molecular weight of 300,000 or lower, wherein a degree of coloration, which is defined as the difference in absorbance between 420 nm and 720 nm when a 5% by weight aqueous solution of the alginic acid or a salt thereof is subjected to absorption spectrophotometry using a 1-cm cell, is 0.040 or lower.

    摘要翻译: 提供了一种具有低着色度的纯化藻酸或其盐及其制备方法。 一种重均分子量为30000以下的解聚海藻酸或其盐,其中着色度定义为420nm至720nm之间的吸光度差异,当5重量% 海藻酸或其盐进行吸收分光光度法测定,使用1cm电池,为0.040以下。